XOMA Royalty Corp. (XOMA), Monday announced that its Chief Financial Officer, Thomas Burns, has decided to step down from his position to pursue other professional opportunities. Concurrently, the company has appointed Jeffrey Trigilio as the new CFO. Most recently, he has served as the Chief Financial...
XOMA Corporation (XOMA) announced a profit for second quarter that Drops, from last year but beat the Street estimates. The company's earnings came in at $5.52 million, or $0.44 per share. This compares with $10.22 million, or $0.84 per share, last year. Analysts on average had expected the company...
XOMA Royalty Corporation (XOMA) announced Friday that it has entered into a definitive merger agreement to acquire Turnstone Biologics Corp. (TSBX) for $0.34 per share in cash plus a non-transferable contingent value right or CVR per share. Specific terms of the CVR were not disclosed. The acquisition...
XOMA Royalty Corporation (XOMA) and Turnstone Biologics Corp. (TSBX) Friday said that they have entered into an agreement to acquire Turnstone by XOMA Royalty for $0.34 per share in cash plus one non-transferable contingent value right (CVR). As per the deal, XOMA Royalty will commence a tender offer...
XOMA Corporation (XOMA) revealed Loss for fourth quarter of -$13.82 million The company's earnings came in at -$13.82 million, or -$1.65 per share. This compares with -$40.83 million, or -$4.04 per share, last year. The company's revenue for the period rose 498.5% to $28.49 million from $4.76...
August 13, 2026 05:33 ET The World Health Organization’s cancer research agency, the International Agency for Research on Cancer (IARC), has classified three widely used medicines as carcinogenic to humans.